戻る Agenda
Updates from the Middle East Region: Key Insights from Agencies & Industry on the Regulatory Environment, Opportunities and the Challenges; Sharing Best Practices of Reliance Model Implementation
Session Chair(s)
Greg Jordinson, MSC
Policy Liaison
Johnson & Johnson, United Kingdom
This session is an opportunity to hear from leading regional health authorities about their role in the region, their vision for the future and the roadmap to achieve that vision. The session will also hear about the hurdles and opportunities for both industry and the health authorities. The presentations will be followed by a Q & A session taking questions from the audience.
Speaker(s)
Panellist
Hassaan S Alwohaibi
Saudi Food and Drug Authority (SFDA), Saudi Arabia
Executive Director of Regulatory Affairs Directorate
Panelist
Inas Chehimi
Novartis Pharma Services AG, United Arab Emirates
Head Regulatory Affairs - Middle East & North Africa